Brief: Egetis Therapeutics Q4 Loss Narrows To SEK 32.1 Mln

Egetis Therapeutics AB (publ)

17/02/2022 07:13

Feb 17 (Reuters) - Egetis Therapeutics AB (publ)  EGTX.ST :
    * Q4 QUARTERLY NET REVENUE MSEK 3.5 (5.3)
    * Q4 LOSS MSEK -32.1 (-74.3)

Source text for Eikon:  ID:nMFN8KfnQM 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))